High Prevalence of Human Papillomavirus Type 18 in Oral Potentially Malignant Disorders in Thailand.
Adult
Aged
Female
Human papillomavirus 16
/ isolation & purification
Human papillomavirus 18
/ isolation & purification
Humans
Leukoplakia, Oral
/ epidemiology
Lichen Planus, Oral
/ epidemiology
Male
Middle Aged
Papillomavirus Infections
/ epidemiology
Precancerous Conditions
/ epidemiology
Prevalence
Risk Factors
Thailand
/ epidemiology
Oral Potentially Malignant Disorders
Oral leukoplakia
Oral lichen planus
high-risk human papillomavirus
Journal
Asian Pacific journal of cancer prevention : APJCP
ISSN: 2476-762X
Titre abrégé: Asian Pac J Cancer Prev
Pays: Thailand
ID NLM: 101130625
Informations de publication
Date de publication:
01 Jun 2021
01 Jun 2021
Historique:
received:
03
03
2021
entrez:
28
6
2021
pubmed:
29
6
2021
medline:
15
12
2021
Statut:
epublish
Résumé
The main objectives of this study were to investigate the detection rate of high-risk human papillomavirus types 16 and 18 (high-risk HPV16/18) in oral potentially malignant disorders (OPMDs) including oral leukoplakia (OL) and oral lichen planus (OLP) in a Thai population and their associations with demographic, risk habits, and clinicopathologic features. Paraffin-embedded formalin-fixed specimens from 101 OL and 59 OLP patients with patients' demographic, risk habits, and clinicopathologic data were collected. Conventional qualitative polymerase chain reaction was used to detect high-risk HPV16/18 DNA. Associations between high-risk HPV type 16/18 and demographic, clinicopathologic, risk factors (tobacco and alcohol uses) of OPMDs were analysed by Chi-square or Fisher's exact test. The results with p value less than 0.05 were considered statistically significant. HPV16/18 DNA was found in both OL and OLP groups with the detection rate of 19.8% and 18.6%, respectively. Approximately 90% of high-risk HPV were HPV18 subtype. Additionally, in OL group, high-risk HPV was found more frequently in patients with moderate/severe dysplasia than that in mild dysplasia. Interestingly, in OLP group, high-risk HPV was only detected in atrophic/ulcerative subtypes. None of risk factors was associated with high-risk HPV. Approximately 19% of OPMDs were HPV16/18-positive. HPV18 DNA was predominantly detected in both OL and OLP patients (90%). Additionally, the detection rate of high-risk HPV was higher in more severe dysplastic cases of OL and more clinically severe cases of OLP.
Identifiants
pubmed: 34181346
doi: 10.31557/APJCP.2021.22.6.1875
pmc: PMC8418837
pii:
doi:
Types de publication
Journal Article
Langues
eng
Sous-ensembles de citation
IM
Pagination
1875-1881Références
Cancer Epidemiol Biomarkers Prev. 2005 Feb;14(2):467-75
pubmed: 15734974
Int J Oncol. 2007 Apr;30(4):813-23
pubmed: 17332919
Oral Oncol. 2006 May;42(5):461-74
pubmed: 16316774
Indian J Cancer. 2016 Jan-Mar;53(1):206-9
pubmed: 27146781
Dent Res J (Isfahan). 2009 Fall;6(2):82-6
pubmed: 21528036
Oral Surg Oral Med Oral Pathol Oral Radiol. 2018 Jun;125(6):612-627
pubmed: 29396319
Evid Based Dent. 2015 Dec;16(4):102-3
pubmed: 26680515
Oral Surg Oral Med Oral Pathol Oral Radiol Endod. 2004 Dec;98(6):705-11
pubmed: 15583544
Asian Pac J Cancer Prev. 2015;16(13):5525-9
pubmed: 26225705
Indian J Med Sci. 2011 May;65(5):212-21
pubmed: 23364508
Cancers (Basel). 2020 Aug 06;12(8):
pubmed: 32781676
Int J Prev Med. 2014 Apr;5(4):430-8
pubmed: 24829730
Value Health. 2012 Jan-Feb;15(1 Suppl):S29-34
pubmed: 22265063
PLoS One. 2016 Aug 29;11(8):e0161339
pubmed: 27571417
BMC Res Notes. 2017 Dec 4;10(1):682
pubmed: 29202883
Asian Pac J Cancer Prev. 2020 Nov 01;21(11):3349-3355
pubmed: 33247695
Arch Sex Behav. 2016 Feb;45(2):367-82
pubmed: 25403321
J Natl Cancer Inst. 2003 Dec 3;95(23):1772-83
pubmed: 14652239
Asian Pac J Cancer Prev. 2016;17(8):4049-57
pubmed: 27644660
Eur J Oral Sci. 2018 Oct;126 Suppl 1:49-66
pubmed: 30178562
Aust Dent J. 2013 Mar;58(1):2-10; quiz 125
pubmed: 23441786
Virology. 2004 Jun 20;324(1):17-27
pubmed: 15183049
J Oral Pathol Med. 2016 Mar;45(3):155-66
pubmed: 26189354
Heliyon. 2020 Aug 05;6(8):e04625
pubmed: 32793834
Oral Surg Oral Med Oral Pathol Oral Radiol. 2018 Jun;125(6):582-590
pubmed: 29673799
Oral Oncol. 2017 May;68:92-102
pubmed: 28438300
Oral Microbiol Immunol. 2008 Aug;23(4):271-4
pubmed: 18582325
Lancet Infect Dis. 2018 Feb;18(2):198-206
pubmed: 29158102
Med Microbiol Immunol. 2003 Aug;192(3):145-8
pubmed: 12920590
Mol Clin Oncol. 2016 Aug;5(2):241-245
pubmed: 27446557
J Oral Maxillofac Pathol. 2015 May-Aug;19(2):170-4
pubmed: 26604492
Int J Cancer. 2007 Aug 1;121(3):621-32
pubmed: 17405118
ISRN Dent. 2013 May 26;2013:362750
pubmed: 23762572
Anticancer Res. 2010 Sep;30(9):3435-40
pubmed: 20944119
J Infect Dis. 2009 May 1;199(9):1263-9
pubmed: 19320589
Br J Cancer. 2003 Jul 7;89(1):101-5
pubmed: 12838308
Asian Pac J Cancer Prev. 2008 Oct-Dec;9(4):771-5
pubmed: 19256774
Oral Microbiol Immunol. 2009 Aug;24(4):314-8
pubmed: 19572894
Oral Surg Oral Med Oral Pathol Oral Radiol. 2018 Jun;125(6):603-611
pubmed: 29891084
Oral Dis. 2008 Apr;14(3):229-43
pubmed: 18298420
Oral Dis. 2011 Apr;17 Suppl 1:58-72
pubmed: 21382139
Oral Surg Oral Med Oral Pathol Oral Radiol. 2018 Jun;125(6):577-581
pubmed: 29396315
Oral Surg Oral Med Oral Pathol Oral Radiol Endod. 2003 May;95(5):594-600
pubmed: 12738951